Linden Thomas Advisory Services’s AbbVie ABBV Stock Holding History

Linden Thomas Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.04M	Buy	15,463 +422	+3%	+$108K	0.32%	78
2026 Q2	$3.78M	Buy	15,041 +710	+5%	+$153K	0.31%	80
2026 Q1	$3.12M	Buy	14,331 +824	+6%	+$183K	0.3%	95
2025 Q4	$3.09M	Buy	13,507 +407	+3%	+$92.7K	0.31%	86
2025 Q3	$3.03M	Buy	13,100 +152	+1%	+$31K	0.31%	83
2025 Q2	$2.4M	Buy	12,948 +561	+5%	+$104K	0.26%	112
2025 Q1	$2.6M	Buy	12,387 +49	+0.4%	+$9.5K	0.34%	81
2024 Q4	$2.19M	Buy	12,338 +35	+0.3%	+$6.44K	0.28%	113
2024 Q3	$2.43M	Sell	12,303 -37	-0.3%	-$6.9K	0.33%	79
2024 Q2	$2.12M	Sell	12,340 -217	-2%	-$35.9K	0.33%	82
2024 Q1	$2.29M	Buy	12,557 +94	+0.8%	+$16.2K	0.37%	62
2023 Q4	$1.93M	Buy	12,463 +121	+1%	+$17.6K	0.36%	72
2023 Q3	$1.84M	Sell	12,342 -14	-0.1%	-$2.06K	0.41%	56
2023 Q2	$1.66M	Buy	12,356 +345	+3%	+$50.6K	0.37%	73
2023 Q1	$1.91M	Buy	12,011 +1,194	+11%	+$183K	0.47%	47
2022 Q4	$1.75M	Buy	+10,817	New	+$1.66M	0.49%	53

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Linden Thomas Advisory Services's ABBV Position: Q3 2026 in Review

Linden Thomas Advisory Services increased its AbbVie (ABBV) stake by 2.8% in Q3 2026, buying an estimated $108K and bringing the position to 15,463 shares worth $4.04M. The position accounts for 0.32% of the portfolio, ranked #78.

Linden Thomas Advisory Services first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 1,551 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Linden Thomas Advisory Services held 15,463 shares of AbbVie worth $4.04M as of Q3 2026.
Linden Thomas Advisory Services bought 422 AbbVie shares in Q3 2026, an estimated $108K.
AbbVie made up 0.32% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #78 holding.
Linden Thomas Advisory Services first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
1,551 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.